Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence. [electronic resource]
Producer: 20020122Description: 110-7 p. digitalISSN:- 1472-4472
- Antipsychotic Agents -- economics
- Benzodiazepines
- Clozapine -- therapeutic use
- Cost-Benefit Analysis
- Dibenzothiazepines -- therapeutic use
- Health Care Costs
- Humans
- Imidazoles -- therapeutic use
- Indoles -- therapeutic use
- Olanzapine
- Pirenzepine -- analogs & derivatives
- Quetiapine Fumarate
- Randomized Controlled Trials as Topic
- Risperidone -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.